Novo Nordisk, semaglutide
Novo is currently in a golden age of growth. Over the last five years, its trailing-12-month revenue grew by 109%, reaching ...
The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...
At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish ...
In other news, Novo Nordisk announced the results from its phase 3b STEP UP semaglutide trial today. Specifically, the ...
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...
We recently published a list of These 10 Firms Took A Hit on Friday. In this article, we are going to take a look at where ...
It’s taken LVMH nearly a year-and-a-half to wrestle back its spot as Europe’s biggest stock from Novo Nordisk A/S.The Danish ...
Apple stock rises after falling Thursday by the most since August, Alphabet stock is up after the Supreme Court upholds a ban ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback